No Detail Found!

Comparing critically ill ARDS patients with COVID-19 vs. without COVID-19: A prospective, bivariate and multi- variable analysis of 690 patients

Author(s)
Haifa M. Algethamy Department of Anesthesia & Critical Care, King Abdulaziz University Hospital.,Jeddah,Saudi Arabia
Mohammed M. Aboudeif Department of Anesthesia & Critical Care, King Abdulaziz University Hospital.,Jeddah,Saudi Arabia
Moatz O. Alhandi Department of Critical Care, King Salman Medical City, Madina, Saudi Arabia
Fahd Y. Majrashi Department of Critical Care, King Fahd Central Hospital, Jazan, Saudi Arabia.
Shrooq H. Hakami Department of General Surgery & Critical Care, King Abdulaziz Hospital, Jeddah, Saudi Arabia.
Midhat A. Jan Department of General Surgery & Critical Care, King Abdulaziz Hospital, Jeddah, Saudi Arabia.
Hanan A. Kabli Department of General Surgery, King Abdulaziz Hospital, Jeddah, Saudi Arabia.
Mohammed H. Alhomrani Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Kevin P. White Science Right Consulting Services, 195 Dufferin Avenue, Suite 605. London, Ontario N6A 1K7, Canada.
Abstract
Background & objective: Few studies have directly and prospectively compared ICU patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 vs. other causes. Almost all previously-published studies were retrospective and employed historical non-COVID cases. We aimed to identify and compare patient characteristics and predictors of mortality associated with COVID-related vs. non-CIVID-related ARDS. Methodology: We performed a prospective cohort study. Consecutive ARDS patients with or without confirmed COVID-19 admitted to an ICU of a major tertiary-care hospital from March-December 2020 were included. A total of 160 patients with ARDS and positive for COVID-19 and 530 ARDS patients without COVID-19 were enrolled. Data were collected and both bivariate and multivariable analyses performed on COVID-19 status, demographics, morphometrics, comorbidities, presenting symptoms, general health status (APACHE-II) on admission, respiratory parameters and laboratory tests at admission, within 24 h of admission, and pre-intubation. The treatment administered and outcomes were also recorded. Data capture was almost 100%. Results: Numerous clinical differences were detected between 160 patients with COVID-19 vs. 530 patients without COVID-19. Most notably, COVID-19 patients were generally older and heavier, much more frequently presented with fevers/chills, dyspnea, cough, anosmia/ageusia, and sore throat - and had worse outcomes. including over a twofold rate of mortality and five-fold rate of survivors requiring prolonged supplemental oxygen. The presenting symptom dyad of fevers and/or chills and dyspnea was 93.0% sensitive and 63.4% specific for COVID-related ARDS. A baseline APACHE-II Score = 17 and requiring mechanical ventilation was 94.4% sensitive and 70.5% specific for mortality. All 37 COVID patients with an APACHE-II score > 30 died, vs. survival among non-COVID patients with APACHE-II scores up to 40. Conclusion: In one of the first large studies to directly compare contemporary populations of COVID-19 and nonCOVID ICU patients with ARDS, employing multi-variable analysis, numerous differences in patient characteristics, presentation, and outcomes were detected. Abbreviations: APACHE-II - Acute Physiologic Assessment and Chronic Health Evaluation 2nd edition; PaO2 - Partial Pressure of Oxygen; SaO2 - Arterial Oxygen Saturation; BUN - Blood Urea Nitrogen; ALT - Alanine Aminotransferase; AST - Aspartate Aminotransferase; LDH - Lactate Dehydrogenase; NIPPV - Non- Invasive Intermittent Positive Pressure Ventilation; HFNC - High-Flow Nasal Cannula; ECMO - Extra-Corporeal Membrane Oxygenation
Publication Details
Page(s) 652-664
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 6, Year: 2023

Request the full text from PASTIC

Keywords
Treatment, ARDS, predictors, Outcomes, COVID-19, clinical characteristics, Covid-19
References
Richardson S,Hirsch JS,Narasimhan M,Crawford JM,McGinn T,Davidson KW .2020 .Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 323(20) : 2052-9.
Lu L,Zhong W,Bian Z,Li Z,Zhang K,Liang B .2020 .A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect, 07(4) : e18-e25.
. .WHO statement regarding cluster of pneumonia cases in Wuhan, China; 2020 Jan 9. , : .
Worldometer .2022 .. Coronavirus Update (Live): Cases and Deaths from COVID-19 Virus Pandemic, : .
Wu Z,McGoogan JM .2020 .Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323(13) : 1239-42.
Grasselli G,Pesenti A,Cecconi M. .2020 .Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA, 323(16) : 1545-6.
Du RH,Liang LR,Yang CQ,Wang W,Cao TZ,Li M .2020 .Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2. Eur Respir J, 56(3) : 02961-2020.
Mo P,Xing Y,Xiao Y,Deng L,Zhao Q,Wang H .2021 .. Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis, 73(11) : e4208-e13.
Ruan Q,Yang K,Wang W,Jiang L,Song J. . .Clinical predictors of mortality due to COVID-19 based on an analysis of data of. , : .
Wu C,Chen X,Cai Y,Xia J,Zhou X,Xu S .2020 .Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med, 180(7) : 934-43.
Yang HJ,Zhang YM,Yang M,Huang X .2020 .Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2. Eur Respir J, 56(3) : 02439-2020.
Zhou F,Yu T,Du R,Fan G,Liu Y,Liu Z .2020 .Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 6736(20) : 30566-3.
Feng Y,Ling Y,Bai T,Xie Y,Huang J,Li J .2020 .-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med, 201(11) : 0445OC-8.
Bernard GR,Artigas A,Brigham KL,Carlet J,Falke K,Hudson L .1994 .The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 149(3 Pt 1) : 7509706-24.
Dai Q,Wang S,Liu R,Wang H,Zheng J,Yu K .2019 .Risk factors for outcomes of acute respiratory distress syndrome patients: a retrospective study. J Thorac Dis, 02(3) : 673-85.
Bain W,Yang H,Shah FA,Suber T,Drohan C,Al-Yousif N .2021 .-19 versus non-covid-19 acute respiratory distress syndrome: comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes. Ann Am Thorac Soc, 18(7) : 1026OC-10.
Beloncle F,Studer A,Seegers V,Richard JC,Desprez C,Fage N .2021 .Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome. Crit Care, 25(1) : 248.
Bertelli M,Fusina F,Prezioso C,Cavallo E,Nencini N,Crisci S,Is ARDS .2021 .Characterized by Increased Dead Space Ventilation Compared With Non-COVID ARDS. Respir Care, 66(9) : 1406-15.
Hayanga JWA,Kakuturu J,Dhamija A,Asad F,McCarthy P,Sappington P .2022 .Cannulate, extubate, ambulate approach for extracorporeal membrane oxygenation for. COVID-19. J Thorac Cardiovasc Surg, 02(4) : 1132-42.
Kuzmin B,Movsisyan A,Praetsch F,Schilling T,Lux A,Fadel M .2023 .Outcomes of patients with coronavirus disease versus other lung infections requiring venovenous extracorporeal membrane oxygenation. Heliyon, 9(6) : e17441.
McNicholas BA,Rezoagli E,Simpkin AJ,Khanna S,Suen JY,Yeung P .2023 .Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19- related ARDS: insights from two prospective global cohort studies. Crit Care, 27(1) : 3.
Pérez J,Accoce M,Dorado JH,Gilgado DI,Navarro E,Cardoso GP .2023 .Failure of First Transition to Pressure Support Ventilation After Spontaneous Awakening Trials in Hypoxemic Respiratory Failure: Influence of COVID-19. , 5(9) : e0968.
Rasch S,Schmidle P,Sancak S,Herner A,Huberle C,Schulz D .2021 .Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID19 associated ARDS. Sci Rep, 11(1) : 11524.
Seeliger B,Doebler M,Hofmaenner DA,Wendel-Garcia PD,Schuepbach RA,Schmidt JJ .2022 .. Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome. Crit Care Med, 50(6) : e526-e38.
Shoskes A,Huang M,Gedansky A,Hassett C,Buletko AB,Duggal A,Non- A,Acute Respiratory Distress Syndrome: A Matched Case-Control Study A .2022 .MRI of Cerebrovascular Injury Associated With COVID-19 and. Crit Care Med, 50(11) : 1638-43.
Sjoding MW,Admon AJ,Saha AK,Kay SG,Brown CA,Co I .2021 .Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and Acute Respiratory Distress Syndrome. Ann Am Thorac Soc, 18(11) : 1076OC-85.
Tapaskar N,Colon Hidalgo D,Koo G,Shingada K,Rao S,Rodriguez R .2022 .Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study. , 56(2) : 117-23.
María FM,Lorena MR,María Luz FV,Cristina RV,Dolores PD,Fernando TF .2021 .Overall management of emergency general surgery patients during the surge of the COVID-19 pandemic: an analysis of procedures and outcomes from a teaching hospital at the worst hit area in Spain. Eur J Trauma Emerg Surg, 47(3) : 693-702.
Andrianopoulos I,Maniatopoulou T,Lagos N,Kazakos N,Papathanasiou A,Papathanakos G,Non- G .2023 .Acinetobacter baumannii Bloodstream Infections in the COVID-19 Era: A Comparative Analysis between COVID-19 and. Critically Ill Patients. Microorganisms, 11(7) : .
Krinsky N,Sizikov S,Nissim S,Dror A,Sas A,Prinz H .2023 .NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel. J Thromb Haemost, 02(9) : 2569-84.
Lau VI,Mah GD,Wang X,Byker L,Robinson A,Milovanovic L .2023 .Intrapulmonary and Intracardiac Shunts in Adult COVID19 Versus Non-COVID Acute Respiratory Distress Syndrome ICU Patients Using Echocardiography and Contrast Bubble Studies (COVID-Shunt Study): A Prospective, Observational Cohort Study. Crit Care Med, 51(8) : 1023-32.
Bohman JK,Nei SD,Mellon LN,Ashmun RS,Guru PK,-Associated Acute Respiratory Distress Syndrome. J Cardiothorac Vasc Anesth PK .2021 .Physical Therapy and Sedation While on Extracorporeal Membrane Oxygenation. , 06(2) : 524-8.
Hochberg CH,Psoter KJ,Sahetya SK,Nolley EP,Hossen S,Checkley W .2022 .Comparing Prone Positioning Use in COVID19 Versus Historic Acute Respiratory Distress Syndrome. Crit Care Explor, 4(5) : e0695.
Russ M,Menk M,Graw JA,Skrypnikov V,Hunsicker O,Rudat K .2022 .-19 Patients Require Prolonged Extracorporeal Membrane Oxygenation Support for Survival Compared With Non-COVID-. Patients. Crit Care Explor, 4(4) : e0671.
Trigonis R,Smith N,Porter S,Anderson E,Jennings M,Kapoor R .2022 .Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support. J Cardiothorac Vasc Anesth, 36(2) : 414-8.
Ruhi-Williams P,Wu B,Nahmias J,Sagebin F,Fazl Alizadeh R,Gadde KM .2023 .Analysis of Veno-Venous Extracorporeal Membrane Oxygenation for COVID-19 Compared to NonCOVID Etiologies. , 278(3) : 464-70.
Lee A,Durst CR,Rezzadeh KT,Rajaee SS,Penenberg BL,Than JP .2023 .Higher Complication Rate in COVID-19 Recovered Patients Undergoing Primary Total Joint Arthroplasty. J Arthroplasty, 04(7 Suppl 2) : S111-s5.
Tomazini BM,Costa ELV,Besen B,Zampieri FG,Carvalho CRR,Caser EB .2022 .Clinical outcomes and lung mechanics characteristics between COVID-19 and non-COVID-19- associated acute respiratory distress syndrome: a propensity score analysis of two major randomized trials. Rev Bras Ter Intensiva, 34(3) : 20220040-507X.
Pannu AK,Kumar M,Singh P,Shaji A,Ghosh A,Behera A .2021 .Severe Acute Respiratory Infection Surveillance during the Initial Phase of the COVID-19 Outbreak in North India: A Comparison of COVID-19 to Other SARI Causes. Indian J Crit Care Med, 25(7) : 761-7.
Sathe NA,Xian S,Mabrey FL,Crosslin DR,Mooney SD,Morrell ED . .Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach. , : .
Knaus WA,Draper EA,Wagner DP,Zimmerman JE .1985 .APACHE II: a severity of disease classification system. Crit Care Med, 13(10) : 818-29.
Dmytriw AA,Chibbar R,Chen PPY,Traynor MD,Kim DW,Bruno FP .2021 .Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis. Expert Rev Respir Med, 15(10) : 1347-54.
Brault C,Zerbib Y,Kontar L,Fouquet U,Carpentier M,Metzelard M .2020 .- versus non-COVID-19-related Acute Respiratory Distress Syndrome: Differences and Similarities. Am J Respir Crit Care Med, 202(9) : 2025LE-4.
Helms J,Tacquard C,Severac F,Leonard-Lorant I,Ohana M,Delabranche X .2020 .High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med, 46(6) : 1089-98.
Bhatraju PK,Ghassemieh BJ,Nichols M,Kim R,Jerome KR,Nalla AK .2020 .. in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med, 382(21) : 2012-22.
Shah SJ,Barish PN,Prasad PA,Kistler A,Neff N,Kamm J .2020 .Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19. , 27 : 100518.
Higgins TL,Stark MM,Henson KN,Freeseman-Freeman L. Coronavirus Disease 2019 ICU Patients KN . .Have Higher-ThanExpected Acute Physiology and Chronic Health EvaluationAdjusted Mortality and. , : .
Zou X,Li S,Fang M,Hu M,Bian Y,Ling J .2020 .Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019. Crit Care Med, 48(8) : e657-e65.
Izcovich A,Ragusa MA,Tortosa F,Lavena Marzio MA,Agnoletti C,Bengolea A .2020 .Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One, 15(11) : e0241955.
Imazio M,Klingel K,Kindermann I,Brucato A,De Rosa FG,Adler Y .2020 .-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?. Heart, 106(15) : 317186-31.
Cheng L,Li H,Li L,Liu C,Yan S,Chen H .2020 .Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal, 34(10) : e23618.
Higgins V,Sohaei D,Diamandis EP,Prassas I. .2020 .COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci, 58(5) : 297-310.
Cao J,Tu WJ,Cheng W,Yu L,Liu YK,Hu X .2020 .Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan. Clin Infect Dis, 71(15) : 748-55.
Warren MA,Zhao Z,Koyama T,Bastarache JA,Shaver CM,Semler MW .2018 .Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS. - 211280, 73(9) : 840-6.
0

Citations

0

Downloads

65

Views